SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

NCT00114972 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1800

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Polymer-based Paclitaxel-Eluting TAXUS Express2-SR Stent
PROCEDURE: Coronary Artery Bypass Surgery

Sponsor

Boston Scientific Corporation

Collaborators

[object Object]